Phibro Animal Health Corporation (PAHC) Soars 39% in Q4, Stock Up 80% YTD on Zoetis Acquisition Boost

We recently compiled a list of the 12 Healthcare Stocks with Insider Buying in 2025. Phibro Animal Health Corporation is one of them.

Phibro Animal Health Corporation (NASDAQ:PAHC) reported strong growth in 2025, driven by expanded product lines and rising global demand. Operating across about 90 countries, the company serves both food and companion animals through its portfolio of medicated feed additives (MFAs), nutritional products, vaccines, and specialty ingredients.

For fiscal Q4 2025, Phibro Animal Health Corporation (NASDAQ:PAHC)’s net sales surged 39% to $378.7 million, fueled by a 53% increase in its Animal Health segment. MFA sales jumped 77%, largely from the successful acquisition and integration of Zoetis’ MFA portfolio and robust demand in Latin America. Specialty nutritional products and vaccines also contributed to gains. Overall, fiscal 2025 net sales rose 27% to $1.29 billion, with significant improvements in net income and adjusted EBITDA.

The Zoetis acquisition, which added more than 37 products and six manufacturing sites worldwide, has been central to Phibro’s recent momentum. The firm is also expanding in the companion animal market and seeing global adoption of OmniGen-AF, a nutritional supplement for the dairy industry.

Phibro Animal Health Corporation (PAHC) Soars 39% in Q4, Stock Up 80% YTD on Zoetis Acquisition Boost

Investor confidence has followed these results. PAHC’s stock is up more than 80% year-to-date in 2025, outpacing both peers and the broader market. Analysts have raised earnings forecasts for fiscal 2025 and 2026, reflecting optimism around continued growth. Looking ahead, PAHC projects $1.43 to $1.48 billion in revenue and $225–$235 million in adjusted EBITDA for fiscal 2026, underscoring confidence in its trajectory.

While we acknowledge the risk and potential of PAHC as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than PAHC and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy NOW 

Disclosure: None.